Mubasher TV
Contact Us Advertising   العربية

Sector News

Photo Archive
13 April 09:30 AM Avalon Pharma unveils SAR 25m cash dividends for H2-24
Riyadh – Mubasher: The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million for the second half (H2) of 2024, according to a bourse filing. The Saudi group will disburse SAR 1.25 …
Photo Archive
8 April 09:50 AM SPIMACO appoints Chairman, Vice Chairman
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) unveiled key appointments for a new board term that will end on 2 April 2029. SPIMACO named Khalid Abdulrahman Alqwaiz as the board’s Chairman for the …
Photo Gallery
25 February 08:42 PM Jamjoom Pharma registers 22% higher profits backed by expansion in Egypt
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) posted 21.93% higher net profits at SAR 356.52 million in 2024, compared to SAR 292.40 million in 2023. Revenues jumped by 19.77% year-on-year (YoY) to SAR 1.31 billion as …
Photo Archive
19 January 04:05 PM SPIMACO rolls out SAR 164m deal
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) inked a SAR 164.05 million agreement on 16 January 2025. SPIMACO penned the deal with Ibrahim Al Hudhaifi International Company to sell and distribute …
Photo Gallery
15 January 03:28 PM Jamjoom Pharma partakes in 43rd J.P. Morgan Healthcare Conference 2025
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) is participating in the 43rd Annual J.P. Morgan Healthcare Conference that is taking place in the US, according to a press release. The conference is being held on 13-16 …
Photo Archive
5 January 10:09 PM TASI expected to trade between 11,300 to 13,300pts in 2025 – Report
Riyadh – Mubasher: SNB Capital, a regional financial institution, recently projected in a report that the benchmark All Share Index (TASI) of the Saudi Exchange (Tadawul) would trade between 11,300 to 13,300 points (pts) in 2025, reflecting a …
Photo Archive
11 November 2024 04:37 PM SPIMACO’s profits leap 279% in 9M-24
Riyadh – Mubasher: The net profits of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) enlarged by 278.77%  yearly to SAR 67.80 million in the first nine months (9M) of 2024 from SAR 17.90 million. The Saudi group …
Photo Archive
27 October 2024 00:40 PM Jamjoom Pharma posts SAR 305m net profits in 9M-24
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits valued at SAR 304.92 million in the first nine months (9M) of 2024, marking a 22.90% year-on-year (YoY) leap from SAR 247.92 million. The revenues hit …
Photo Archive
7 August 2024 02:47 PM Jamjoom Pharma’s profits rise 23% in H1-24; dividends unveiled
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged net profits amounting to SAR 209.92 million in the first half (H1) of 2024, marking an annual plunge of 22.99% from SAR 170.67 million. The revenues hit SAR 731.20 …
Photo Archive
31 July 2024 11:58 AM Avalon Pharma’s board approves dividends for H1-24
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) is set to disburse cash dividends worth SAR 15 million, equivalent to 7.50% of the capital, for the first half (H1) of 2024. Avalon Pharma will pay out a dividend of …
Photo Archive
9 July 2024 11:49 AM Avalon Pharma obtains SAR 70m from Emirates NBD
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) secured a Sharia facility amounting to SAR 70 million from Emirates NBD on 8 July 2024. The Saudi company obtained the loan for one year to finance its operations, …
Photo Archive
8 July 2024 09:15 AM Jamjoom Pharma secures facility deal for unit in Algeria
Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) agreed to provide a corporate guarantee to support the issuance of a credit facility for its joint venture (JV) in Algeria, Jamjoom Algeria Lil Dawa SPA. A …
Photo Archive
5 June 2024 11:33 AM Jamjoom Pharma’s shareholders approve annual dividends for 2023
Riyadh – Mubasher: The extraordinary general meeting (EGM) of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) approved cash dividends amounting to SAR 105 million for the second half (H2) of 2023. The total dividends distributed and …
Photo Archive
9 May 2024 00:08 PM Jamjoom Pharma registers SAR 103m net profits in Q1-24
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved 22% year-on-year (YoY) higher net profits at SAR 102.96 million in the first quarter (Q1) of 2024, versus SAR 84.40 million. Revenues amounted to SAR 385.46 …
Photo Archive
4 April 2024 02:12 PM Jamjoom Pharma’s board proposes SAR 105m dividends
Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recommended the distribution of SAR 105 million in cash dividends for 2023. The suggested dividends amount to SAR 1.50 per share to be distributed to 70 …
Photo Archive
31 March 2024 03:13 PM SPIMACO’s net loss plunges 98% YoY in 2023
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) posted a 98% year-on-year (YoY) drop in net loss to SAR 3 million in 2023 from SAR 171 million. Revenues jumped 16% YoY to SAR 1.65 billion last year …
Photo Archive
25 March 2024 00:32 PM Jamjoom Pharma posts 71% YoY higher profit in 2023
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged a 70.68% year-on-year (YoY) jump in net profit to SAR 292.40 million in 2023 from SAR 171.31 million. Revenues grew 20.09% YoY to SAR 1.10 billion last year from …
Photo Archive
21 February 2024 11:53 AM SPIMACO confirms Jerome Cabannes as CEO
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has appointed Jerome Cabannes as CEO starting 20 February. Cabannes has been serving as Acting CEO since October 2023, previously holding the position …
Photo Archive
23 January 2024 06:04 PM SPIMACO teams up with Recbio for recombinant HPV-9 vaccine
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) inked a term sheet with Jiangsu Recbio Technology Company Limited for the licensing, supply, and technology transfer of Recombinant Human …
Photo Archive
21 January 2024 04:05 PM Jamjoom Pharma secures funding to back JV in Algeria
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has secured a short-term revolving banking facility from the Bank of NATIXIS Algeria with a total amount of DZD 1.30 billion (SAR 36.20 million). The loan will support the …
Photo Archive
6 December 2023 04:40 PM SPIMACO mulls 68% equity acquisition in Swiss Osmopharm, to exit SPIMACO Misr
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) signed sale and purchase agreements (SPAs) to acquire a 68% stake in Swiss-based Osmopharm and exit its 76.40% equity in Egypt-based SPIMACO Misr for …
Photo Archive
22 November 2023 03:23 PM Saudi Jamjoom Pharma unveils financing for JV in Algeria
Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) agreed to provide a corporate guarantee to Al Salam Bank Algeria to back the issuance of a Shariah-compliant short-term revolving banking facility. The …
Photo Archive
7 November 2023 04:34 PM Jamjoom Pharma registers 77.5% leap in 9M-23 profits
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) posted an annual hike of 77.58% in net profit after Zakat and tax to SAR 247.90 million during the first nine months (9M) of 2023, versus SAR 139.60 million. The revenues …
Photo Archive
7 November 2023 02:38 PM SPIMACO announces 9M-23 financial results, accumulated losses
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) turned profitable at SAR 40.40 million in the first nine months (9M) of 2023, against net losses of SAR 67 million in 9M-22. Revenues amounted to SAR …
Photo Archive
13 August 2023 10:48 AM Jamjoom Pharma’s profit near SAR 171m in H1-23; dividends announced
Riyadh – Mubasher: The net profits after Zakat and tax of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) hiked by 81.59% to SAR 170.70 million in the first half (H1) of 2023, versus SAR 94 million in H1-22. Revenues stood at SAR 600.30 …